Baillie Gifford INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Baillie Gifford ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1,249
+124800.0%
1010.0%0.00%
Q3 2022$10.0%1010.0%0.00%
Q2 2022$1
-50.0%
1010.0%0.00%
Q1 2022$20.0%1010.0%0.00%
Q4 2021$2
+100.0%
1010.0%0.00%
Q3 2021$1
-50.0%
1010.0%0.00%
Q2 2021$20.0%1010.0%0.00%
Q1 2021$20.0%101
+17.4%
0.00%
Q4 2020$2860.00%